BioPharmX completes direct public offering

BioPharmX Corp. (NYSE-M:BPMX), Menlo Park, Calif. Business: Drug delivery, Dermatology, Neurology Date completed: 2016-09-26 Type: Direct public offering Raised: $930,000 Shares: 1.6 million Price: $0...